Good News About Multiple Myeloma
Multiple myeloma news 2017 - Combining the proteasome inhibitor Kyprolis (carfilzomib) with dexamethasone is beneficial for person patients with multiple myeloma who have obtained at the least one prior therapy, the Scottish drug treatments Consortium (SMC) determined.
The SMC advises the Scottish countrywide health carrier (NHS) boards and their Area Drug and Therapeutics Committees (ADTCs)
The SMC advises the Scottish countrywide health carrier (NHS) boards and their Area Drug and Therapeutics Committees (ADTCs)
0 Response to "Good News About Multiple Myeloma"
Post a Comment